drugset / Trial / NCT01008618

A Confirmatory Study of Fentanyl in Participants With Osteoarthritis or Low Back Pain

NCT01008618

Phase 3 Completed 218 enrolled Janssen Pharmaceutical K.K.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate efficacy and safety of fentanyl in opioid-naive participants with osteoarthritis (disorder, which is seen mostly in older persons, in which the joints become painful and stuff) or low back pain who cannot obtain a sufficient analgesic effect by the treatment of non-opioid analgesics (drug used to control pain).

Timeline

Start
2009-01
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 12.5 ug Other
Subject Fentanyl Other / unclassified 25 ug Other
Subject Fentanyl Other / unclassified 37.5 ug Other
Subject Fentanyl Other / unclassified 50 ug Other